Here’s our August rapid-fire update on all 32 stocks in Cramer’s Charitable Trust portfolio

Published Thu, Aug 4 20224:25 PM EDTUpdated Fri, Aug 5 202210:01 AM EDT

Kevin Stankiewicz @in/kevinstankiewicz @kevin_stank

Here's a rapid-fire update on every stock in the CNBC Investing Club portfolio. Jim Cramer ran through each one of them Thursday during the August edition of our "Monthly Meeting." Apple (AAPL) — For Club members who haven't found the "right" opportunity to start a position in Apple yet, we say now is the time. Start with a small purchase and be patient, as you can build it up over time. AbbVie (ABBV) — We're on recession watch, which means owning defensive drug stocks is strategically important. While one of AbbVie's key drugs, Humira, goes off-patent next year, we think the company has plenty else going for it including a roughly 4% dividend based on Thursday's stock price. Advanced Micro Devices (AMD) — The quarter AMD reported Tuesday night wasn't perfect thanks to an expected slowdown in PCs and gaming chips, but the company's strategic shift toward lucrative enterprise markets under CEO Lisa Su continues to progress. We're still long-term bulls. Amazon (AMZN) — After a strong quarter that demonstrated management's commitment to fixing overexpansion issues, we look at Amazon here in a similar way to Apple if you're not yet invested. Start a small position and then wait. Bausch Health Companies (BHC) — We are still incredibly frustrated and apologetic for how poorly our investment in Bausch Health has gone. It's cost the Charitable Trust a ton of money. Costco Wholesale (COST) — Owning a lot of industrials or retailers when a recession could be on the near-term horizon is ill-advised. That said, we're willing to stick with Costco because we think it's the best-run retailer in the world. Its solid July comparable sales figures , released Wednesday night, backed up our belief. Salesforce (CRM) — While we sold 30 shares Wednesday, it was done out of discipline, not eroding confidence in the enterprise software firm's long-term story. We're glad to see the company's big Dreamforce conference scheduled to take place next month after two years of Covid-related alterations. It's historically been a valuable event for co-CEO Marc Benioff to conduct business. Cisco Systems (CSCO) — We trimmed our position Tuesday , bringing Cisco to a roughly 2% weighting in the portfolio. The reason for that sale is we're worried persistent supply chain issues could cause the networking company to report weaker-than-expected earnings later this month. Coterra Energy (CTRA) — Our position in Coterra was started this year to help us hedge the portfolio against inflation, given skyrocketing energy prices were a main contributor. For Coterra, specifically, we continue to like it here because of its strong capital returns and sizable natural gas business. The latter is especially valuable if the U.S. keeps exporting liquified natural gas (LNG) at its current pace. Chevron (CVX) — Our purchase of 145 Chevron shares in December has proved to be wise, although we recognize the decline in oil prices may spook some investors. Danaher (DHR) — Discipline required us to trim some Danaher on Friday, even though we found its most recent quarterly